1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent Anti-HIV activity
作者:Jeffrey J. Hale、Richard J. Budhu、Edward B. Holson、Paul E. Finke、Bryan Oates、Sander G. Mills、Malcolm MacCoss、Sandra L. Gould、Julie A. DeMartino、Martin S. Springer、Salvatore Siciliano、Lorraine Malkowitz、William A. Schleif、Daria Hazuda、Michael Miller、Joseph Kessler、Renee Danzeisen、Karen Holmes、Janet Lineberger、Anthony Carella、Gwen Carver、Emilio Emini
DOI:10.1016/s0960-894x(01)00545-5
日期:2001.10
Investigations of the structure-activity relationships of 1,3,4-trisubstituted pyrrolidine human CCR5 receptor antagonists afforded orally bioavailable compounds with the ability to inhibit HIV replication in vitro. (C) 2001 Elsevier Science Ltd. All rights reserved.